1
|
Alexiev U, Rühl E. Visualization of Nanocarriers and Drugs in Cells and Tissue. Handb Exp Pharmacol 2024; 284:153-189. [PMID: 37566121 DOI: 10.1007/164_2023_684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/12/2023]
Abstract
In this chapter, the visualization of nanocarriers and drugs in cells and tissue is reviewed. This topic is tightly connected to modern drug delivery, which relies on nanoscopic drug formulation approaches and the ability to probe nanoparticulate systems selectively in cells and tissue using advanced spectroscopic and microscopic techniques. We first give an overview of the breadth of this research field. Then, we mainly focus on topical drug delivery to the skin and discuss selected visualization techniques from spectromicroscopy, such as scanning transmission X-ray microscopy and fluorescence lifetime imaging. These techniques rely on the sensitive and quantitative detection of the topically applied drug delivery systems and active substances, either by exploiting their molecular properties or by introducing environmentally sensitive probes that facilitate their detection.
Collapse
Affiliation(s)
- Ulrike Alexiev
- Fachbereich Physik, Freie Universität Berlin, Berlin, Germany.
| | - Eckart Rühl
- Physikalische Chemie, Freie Universität Berlin, Berlin, Germany.
| |
Collapse
|
2
|
Tong X, Chen Y, Mu C, Chen Q, Zhang X, Zeng G, Li Y, Xu Z, Zhao J, Zhen X, Mao C, Lu H, Tai R. A compound Kinoform/Fresnel zone plate lens with 15 nm resolution and high efficiency in soft x-ray. Nanotechnology 2023; 34:215301. [PMID: 36745920 DOI: 10.1088/1361-6528/acb946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Accepted: 02/06/2023] [Indexed: 06/18/2023]
Abstract
X-ray microscope as an important nanoprobing tool plays a prevailing role in nano-inspections of materials. Despite the fast advances of high resolution focusing/imaging reported, the efficiency of existing high-resolution zone plates is mostly around 5% in soft x-ray and rapidly goes down to 1%-2% when the resolution approaches 10 nm. It is well known that the rectangular zone shape, beamstop, limited height/width ratios, material absorption of light and structural defects are likely responsible for the limited efficiency. Although zone plates with Kinoform profile are supposed to be efficient, progress for achieving both high resolution (<30 nm) and high efficiency (>5%) have hardly been addressed in soft x-ray. In this work, we propose a compound Kinoform/Fresnel zone plate (CKZP) by combing a dielectric Kinoform zone plate with a 15 nm resolution zone plate. Greyscale electron beam lithography was applied to form the 3D Kinoform zone plate and atomic layer deposition was carried out to form the binary zone plate. Optical characterizations demonstrated 15 nm resolution focusing/imaging with over 7.8% efficiency in soft x-ray. The origin of the efficiency improvement behind the proposed compound lens is theoretically analyzed and discussed.
Collapse
Affiliation(s)
- Xujie Tong
- Nanolithography and Application Research Group, School of Information Science and Technology, Fudan University, Shanghai 200433, People's Republic of China
| | - Yifang Chen
- Nanolithography and Application Research Group, School of Information Science and Technology, Fudan University, Shanghai 200433, People's Republic of China
| | - Chengyang Mu
- Nanolithography and Application Research Group, School of Information Science and Technology, Fudan University, Shanghai 200433, People's Republic of China
| | - Qiucheng Chen
- Nanolithography and Application Research Group, School of Information Science and Technology, Fudan University, Shanghai 200433, People's Republic of China
| | - Xiangzhi Zhang
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China
| | - Guang Zeng
- State Key Laboratory of ASIC and System, Shanghai Institute of Intelligent, Electronics & Systems, School of Microelectronics, Fudan University, Shanghai 200433, People's Republic of China
| | - Yuchun Li
- State Key Laboratory of ASIC and System, Shanghai Institute of Intelligent, Electronics & Systems, School of Microelectronics, Fudan University, Shanghai 200433, People's Republic of China
| | - Zijian Xu
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China
| | - Jun Zhao
- Nanolithography and Application Research Group, School of Information Science and Technology, Fudan University, Shanghai 200433, People's Republic of China
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China
| | - Xiangjun Zhen
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China
| | - Chengwen Mao
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China
| | - Hongliang Lu
- State Key Laboratory of ASIC and System, Shanghai Institute of Intelligent, Electronics & Systems, School of Microelectronics, Fudan University, Shanghai 200433, People's Republic of China
| | - Renzhong Tai
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China
| |
Collapse
|
3
|
Pena-Rodríguez E, García-Berrocoso T, Vázquez Fernández E, Otero-Espinar FJ, Abian J, Fernández-Campos F. Monitoring dexamethasone skin biodistribution with ex vivo MALDI-TOF mass spectrometry imaging and confocal Raman microscopy. Int J Pharm 2023; 636:122808. [PMID: 36889415 DOI: 10.1016/j.ijpharm.2023.122808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 03/01/2023] [Accepted: 03/03/2023] [Indexed: 03/08/2023]
Abstract
Two of the most promising techniques in terms of ex vivo skin imaging and quantifying are confocal Raman microscopy and MALDI-TOF mass spectrometry imaging (MALDI-TOF MSI). Both techniques were set up, and the semiquantitative skin biodistribution of previously developed dexamethasone (DEX) loaded lipomers was compared using Benzalkonium chloride (BAK) as a tracer of the nanoparticles. In MALDI-TOF MSI, DEX was derivatised with GirT (DEX-GirT) and the semiquantitative biodistribution of both DEX-GirT and BAK was successfully obtained. The amount of DEX measured by confocal Raman microscopy was higher than that measured by MALDI-TOF MSI, but MALDI-TOF MSI proved to be a more suitable technique for tracing BAK. An absorption-promoting tendency of DEX loaded in lipomers versus a free-DEX solution was observed in confocal Raman microscopy. The higher spatial resolution of confocal Raman microscopy (350 nm) with respect to MALDI-TOF MSI (50 μm) allowed to observe specific skin structures like hair follicles. Nevertheless, the faster sampling rate of MALDI-TOF-MSI, permitted the analysis of larger tissue regions. In conclusion, both techniques allowed to simultaneously analyze semiquantitative data together with qualitative images of biodistribution, which is a very helpful tool when designing nanoparticles that accumulate in specific anatomical regions.
Collapse
Affiliation(s)
- Eloy Pena-Rodríguez
- Laboratory Reig Jofre, R&D Department, 08970, Sant Joan Despí, Barcelona, Spain.
| | - Teresa García-Berrocoso
- Biological and Environmental Proteomics, Institut d'Investigacions Biomèdiques de Barcelona, Consejo Superior de Investigaciones Científicas (IIBB-CSIC), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Laboratorio de Proteómica CSIC/Universitat Autònoma de Barcelona (UAB), IIBB-CSIC, Barcelona, Spain
| | - Ezequiel Vázquez Fernández
- Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), Santiago de Compostela, Spain
| | - Francisco J Otero-Espinar
- Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), Santiago de Compostela, Spain; Parqueasil Group, Health Research Institute of Santiago de Compostela (FIDIS), Santiago de Compostela, Spain; Institute of Materials (iMATUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.
| | - Joaquin Abian
- Biological and Environmental Proteomics, Institut d'Investigacions Biomèdiques de Barcelona, Consejo Superior de Investigaciones Científicas (IIBB-CSIC), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Laboratorio de Proteómica CSIC/Universitat Autònoma de Barcelona (UAB), IIBB-CSIC, Barcelona, Spain
| | | |
Collapse
|
4
|
Prado VC, Moenke K, Osmari BF, Pegoraro NS, Oliveira SM, Cruz L. Development of Guar Gum Hydrogel Containing Sesamol-Loaded Nanocapsules Designed for Irritant Contact Dermatitis Treatment Induced by Croton Oil Application. Pharmaceutics 2023; 15:285. [PMID: 36678913 PMCID: PMC9861215 DOI: 10.3390/pharmaceutics15010285] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Revised: 01/11/2023] [Accepted: 01/12/2023] [Indexed: 01/18/2023] Open
Abstract
Irritant contact dermatitis is usually treated with corticosteroids, which cause expressive adverse effects. Sesamol is a phenolic compound with anti-inflammatory and antioxidant properties. This study was designed to evaluate a hydrogel containing sesamol-loaded ethylcellulose nanocapsules for the treatment of irritant contact dermatitis. The nanocapsules presented a size in the nanometric range, a negative zeta potential, a sesamol content close to the theoretical value (1 mg/mL), and a 65% encapsulation efficiency. Nanoencapsulation protected sesamol against UVC-induced degradation and increased the scavenging activity assessed by ABTS and DPPH radicals. The hydrogels were prepared by thickening the nanocapsule suspensions with guar gum (2.5%). The hydrogels maintained the nanometric size of the nanocapsules and a sesamol content of approximately 1 mg/g. The HET-CAM assay classified the hydrogels as nonirritating. The in vitro release of the hydrogel containing sesamol in the nanoencapsulated form demonstrated an initial burst effect followed by a prolonged sesamol release and a lower skin permeation in comparison with the hydrogel containing free sesamol. In addition, it exhibited the best anti-inflammatory effect in the irritant contact dermatitis model induced by croton oil, reducing ear edema and inflammatory cells infiltration, similar to dexamethasone (positive control). Therefore, the hydrogel containing sesamol in the nanoencapsulated form seemed to have a therapeutic potential in treating irritant contact dermatitis.
Collapse
Affiliation(s)
- Vinicius Costa Prado
- Laboratório de Tecnologia Farmacêutica, Departamento de Farmácia Industrial, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil
| | - Kauani Moenke
- Laboratório de Tecnologia Farmacêutica, Departamento de Farmácia Industrial, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil
| | - Bárbara Felin Osmari
- Laboratório de Tecnologia Farmacêutica, Departamento de Farmácia Industrial, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil
| | - Natháli Schopf Pegoraro
- Laboratório de Neurotoxicidade e Psicofarmacologia, Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil
| | - Sara Marchesan Oliveira
- Laboratório de Neurotoxicidade e Psicofarmacologia, Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil
| | - Letícia Cruz
- Laboratório de Tecnologia Farmacêutica, Departamento de Farmácia Industrial, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil
| |
Collapse
|
5
|
Germer G, Ohigashi T, Yuzawa H, Kosugi N, Flesch R, Rancan F, Vogt A, Rühl E. Improved Skin Permeability after Topical Treatment with Serine Protease: Probing the Penetration of Rapamycin by Scanning Transmission X-ray Microscopy. ACS Omega 2021; 6:12213-12222. [PMID: 34056375 PMCID: PMC8154144 DOI: 10.1021/acsomega.1c01058] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Accepted: 04/07/2021] [Indexed: 05/05/2023]
Abstract
Drug penetration in human skin ex vivo following a modification of skin barrier permeability is systematically investigated by scanning transmission X-ray microscopy. Element-selective excitation is used in the O 1s regime for probing quantitatively the penetration of topically applied rapamycin in different formulations with a spatial resolution reaching <75 nm. The data were analyzed by a comparison of two methods: (i) two-photon energies employing the Beer-Lambert law and (ii) a singular value decomposition approach making use of the full spectral information in each pixel of the X-ray micrographs. The latter approach yields local drug concentrations more reliably and sensitively probed than the former. The present results from both approaches indicate that rapamycin is not observed within the stratum corneum of nontreated skin ex vivo, providing evidence for the observation that this high-molecular-weight drug inefficiently penetrates intact skin. However, rapamycin is observed to penetrate more efficiently the stratum corneum when modifications of the skin barrier are induced by the topical pretreatment with the serine protease trypsin for variable time periods ranging from 2 to 16 h. After the longest exposure time to serine protease, the drug is even found in the viable epidermis. High-resolution micrographs indicate that the lipophilic drug preferably associates with corneocytes, while signals found in the intercellular lipid compartment were less pronounced. This result is discussed in comparison to previous work obtained from low-molecular-weight lipophilic drugs as well as polymer nanocarriers, which were found to penetrate the intact stratum corneum exclusively via the lipid layers between the corneocytes. Also, the role of the tight junction barrier in the stratum granulosum is briefly discussed with respect to modifications of the skin barrier induced by enhanced serine protease activity, a phenomenon of clinical relevance in a range of inflammatory skin disorders.
Collapse
Affiliation(s)
- Gregor Germer
- Physical
Chemistry, Freie Universität Berlin, Arnimallee 22, Berlin 14195, Germany
| | - Takuji Ohigashi
- UVSOR
Synchrotron Facility, Institute for Molecular
Science, Okazaki 444-8585, Japan
| | - Hayato Yuzawa
- UVSOR
Synchrotron Facility, Institute for Molecular
Science, Okazaki 444-8585, Japan
| | - Nobuhiro Kosugi
- UVSOR
Synchrotron Facility, Institute for Molecular
Science, Okazaki 444-8585, Japan
| | - Roman Flesch
- Physical
Chemistry, Freie Universität Berlin, Arnimallee 22, Berlin 14195, Germany
| | | | - Annika Vogt
- Charité-Universitätsmedizin, Berlin 10117, Germany
| | - Eckart Rühl
- Physical
Chemistry, Freie Universität Berlin, Arnimallee 22, Berlin 14195, Germany
| |
Collapse
|
6
|
Pena-Rodríguez E, Lajarin-Reinares M, Mata-Ventosa A, Pérez-Torras S, Fernández-Campos F. Dexamethasone-Loaded Lipomers: Development, Characterization, and Skin Biodistribution Studies. Pharmaceutics 2021; 13:pharmaceutics13040533. [PMID: 33920403 PMCID: PMC8068797 DOI: 10.3390/pharmaceutics13040533] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Revised: 04/08/2021] [Accepted: 04/08/2021] [Indexed: 11/29/2022] Open
Abstract
Follicular targeting has gained more attention in recent decades, due to the possibility of obtaining a depot effect in topical administration and its potential as a tool to treat hair follicle-related diseases. Lipid core ethyl cellulose lipomers were developed and optimized, following which characterization of their physicochemical properties was carried out. Dexamethasone was encapsulated in the lipomers (size, 115 nm; polydispersity, 0.24; zeta-potential (Z-potential), +30 mV) and their in vitro release profiles against dexamethasone in solution were investigated by vertical diffusion Franz cells. The skin biodistribution of the fluorescent-loaded lipomers was observed using confocal microscopy, demonstrating the accumulation of both lipomers and fluorochromes in the hair follicles of pig skin. To confirm this fact, immunofluorescence of the dexamethasone-loaded lipomers was carried out in pig hair follicles. The anti-inflammatory (via TNFα) efficacy of the dexamethasone-loaded lipomers was demonstrated in vitro in an HEK001 human keratinocytes cell culture and the in vitro cytotoxicity of the nanoformulation was investigated.
Collapse
Affiliation(s)
- Eloy Pena-Rodríguez
- Topical & Oral Development R+D Reig Jofre Laboratories, 08970 Barcelona, Spain; (E.P.-R.); (M.L.-R.)
| | - Maria Lajarin-Reinares
- Topical & Oral Development R+D Reig Jofre Laboratories, 08970 Barcelona, Spain; (E.P.-R.); (M.L.-R.)
| | - Aida Mata-Ventosa
- Molecular Pharmacology and Experimental Therapeutics, Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain; (A.M.-V.); (S.P.-T.)
- Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD), Carlos III Health Institute, 28029 Madrid, Spain
- Sant Joan de Déu Research Institute (IR SJD-CERCA) Esplugues de Llobregat, 08950 Barcelona, Spain
| | - Sandra Pérez-Torras
- Molecular Pharmacology and Experimental Therapeutics, Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain; (A.M.-V.); (S.P.-T.)
- Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD), Carlos III Health Institute, 28029 Madrid, Spain
- Sant Joan de Déu Research Institute (IR SJD-CERCA) Esplugues de Llobregat, 08950 Barcelona, Spain
| | - Francisco Fernández-Campos
- Topical & Oral Development R+D Reig Jofre Laboratories, 08970 Barcelona, Spain; (E.P.-R.); (M.L.-R.)
- Correspondence: ; Tel.: +34-935-507-718
| |
Collapse
|
7
|
Schäfer-Korting M, Zoschke C. How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development. Handb Exp Pharmacol 2021; 265:29-56. [PMID: 32894342 DOI: 10.1007/164_2020_374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/12/2023]
Abstract
Preclinical research struggles with its predictive power for drug effects in patients. The clinical success of preclinically approved drug candidates ranges between 3% and 33%. Regardless of the approach, novel disease models and test methods need to prove their relevance and reliability for predicting drug effects in patients, which is usually achieved by method validation. Nevertheless, validating all models appears unrealistic due to the variety of diseases. Thus, novel concepts are needed to increase the quality of preclinical research.Herein, we introduce qualification as a minimal standard to establish the relevance of preclinical models and test methods. Qualification starts with prioritizing and translating scientific requirements into technical parameters by quality function deployment. Qualified models use authenticated cells, which resemble the corresponding cells in humans in morphology and drug target expression. Moreover, disease models differ from normal models in the expression of relevant biomarkers. As a result, qualified test methods can discriminate effects of treatment standards and the effects of weakly effective or ineffective substances. Observer-blind readout, adequate data documentation, dropout inclusion, and a priori power studies are as crucial as realistic dosage regimens for qualified approaches. Here, we showcase the implementation of qualification. Adjusting the level of model complexity and qualification to three defined phases of preclinical research assures the optimal level of certainty at each step.In conclusion, qualification strengthens the researchers' impact by defining basic requirements that novel approaches must fulfill while still allowing for scientific creativity. Qualification helps to improve the predictive power of preclinical research. Applied to human cell-based models, qualification reduces animal testing, since only effective drug candidates are subjected to final animal testing and subsequently to clinical trials.
Collapse
|
8
|
Lohan SB, Saeidpour S, Colombo M, Staufenbiel S, Unbehauen M, Wolde-Kidan A, Netz RR, Bodmeier R, Haag R, Teutloff C, Bittl R, Meinke MC. Nanocrystals for Improved Drug Delivery of Dexamethasone in Skin Investigated by EPR Spectroscopy. Pharmaceutics 2020; 12:E400. [PMID: 32349460 DOI: 10.3390/pharmaceutics12050400] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Revised: 04/16/2020] [Accepted: 04/24/2020] [Indexed: 01/29/2023] Open
Abstract
Nanocrystals represent an improvement over the traditional nanocarriers for dermal application, providing the advantages of 100% drug loading, a large surface area, increased adhesion, and the potential for hair follicle targeting. To investigate their advantage for drug delivery, compared to a base cream formulation, dexamethasone (Dx), a synthetic glucocorticoid frequently used for the treatment of inflammatory skin diseases, was covalently linked with the paramagnetic probe 3-(carboxy)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy (PCA) to DxPCA. To investigate the penetration efficiency between these two vehicles, electron paramagnetic resonance (EPR) spectroscopy was used, which allows the quantification of a spin-labeled drug in different skin layers and the monitoring of the drug release. The penetration behavior in excised healthy and barrier-disrupted porcine skin was monitored by EPR, and subsequently analyzed using a numerical diffusion model. As a result, diffusion constants and free energy values in the different layers of the skin were identified for both formulations. Dx-nanocrystals showed a significantly increased drug amount that penetrated into viable epidermis and dermis of intact (factor 3) and barrier-disrupted skin (factor 2.1) compared to the base cream formulation. Furthermore, the observed fast delivery of the spin-labeled drug into the skin (80% DxPCA within 30 min) and a successive release from the aggregate unit into the viable tissue makes these nanocrystals very attractive for clinical applications.
Collapse
|
9
|
Dong P, Nikolaev V, Kröger M, Zoschke C, Darvin ME, Witzel C, Lademann J, Patzelt A, Schäfer-Korting M, Meinke MC. Barrier-disrupted skin: Quantitative analysis of tape and cyanoacrylate stripping efficiency by multiphoton tomography. Int J Pharm 2019; 574:118843. [PMID: 31759105 DOI: 10.1016/j.ijpharm.2019.118843] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2019] [Revised: 10/30/2019] [Accepted: 11/01/2019] [Indexed: 01/02/2023]
Abstract
Numerous studies have employed tape stripping (TS) or cyanoacrylate stripping (CS) to induce skin barrier disruption of the stratum corneum (SC) in human and porcine skin. However, the thickness of the remaining SC and the respective changes of the skin permeability have been rarely quantified. By using high-resolution multiphoton tomography, about 5 µm thick SC was found remaining on human skin after the performance of 30 times TS or 2 times CS. 50 tape strips or 4 times CS removed the entire human SC, but on porcine skin 2-3 µm thick SC was still left. TS can only reach the transition zone between the SC and the stratum granulosum because of the limited adhesion, whereas CS was able to remove viable skin layers. Permeation investigations on porcine skin revealed that the apparent permeability coefficient of the hydrophilic nitroxide spin 2,5,5-Tetramethyl-1-pyrrolidinyloxy-3-carboxylic acid increased 15-, 18-, and 21-fold when the SC amount remaining in the skin was 30%, 16%, and 8%, respectively. It is recommended to use at most 30 times TS or 3 times CS to obtain ex vivo barrier-disrupted skin that mimics diseased skin. The study provides quantitative information for the utility of TS and CS in skin penetration research.
Collapse
Affiliation(s)
- Pin Dong
- Freie Universität Berlin, Institute of Pharmacy (Pharmacology & Toxicology), Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology and Allergology, Berlin, Germany
| | - Viktor Nikolaev
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology and Allergology, Berlin, Germany; Institute of Strength Physics and Materials Science, Siberian Branch of Russian Academy of Sciences (ISPMS SB RAS), Tomsk, Russia; Tomsk State University, Faculty of Physics, Tomsk, Russia
| | - Marius Kröger
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology and Allergology, Berlin, Germany
| | - Christian Zoschke
- Freie Universität Berlin, Institute of Pharmacy (Pharmacology & Toxicology), Berlin, Germany
| | - Maxim E Darvin
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology and Allergology, Berlin, Germany
| | - Christian Witzel
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Division of Plastic and Reconstructive Surgery, Department of Surgery, CVK CCM, Berlin, Germany
| | - Jürgen Lademann
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology and Allergology, Berlin, Germany
| | - Alexa Patzelt
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology and Allergology, Berlin, Germany
| | - Monika Schäfer-Korting
- Freie Universität Berlin, Institute of Pharmacy (Pharmacology & Toxicology), Berlin, Germany
| | - Martina C Meinke
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
| |
Collapse
|
10
|
Schulz R, Yamamoto K, Klossek A, Rancan F, Vogt A, Schütte C, Rühl E, Netz RR. Modeling of Drug Diffusion Based on Concentration Profiles in Healthy and Damaged Human Skin. Biophys J 2019; 117:998-1008. [PMID: 31400921 DOI: 10.1016/j.bpj.2019.07.027] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2019] [Revised: 06/23/2019] [Accepted: 07/15/2019] [Indexed: 11/21/2022] Open
Abstract
Based on experimental drug concentration profiles in healthy as well as tape-stripped ex vivo human skin, we model the penetration of the antiinflammatory drug dexamethasone into the skin layers by the one-dimensional generalized diffusion equation. We estimate the position-dependent free-energy and diffusivity profiles by solving the conjugated minimization problem, in which the only inputs are concentration profiles of dexamethasone in skin at three consecutive penetration times. The resulting free-energy profiles for damaged and healthy skin show only minor differences. In contrast, the drug diffusivity in the first 10 μm of the upper skin layer of damaged skin is 200-fold increased compared to healthy skin, which reflects the corrupted barrier function of tape-stripped skin. For the case of healthy skin, we examine the robustness of our method by analyzing the behavior of the extracted skin parameters when the number of input and output parameters are reduced. We also discuss techniques for the regularization of our parameter extraction method.
Collapse
|
11
|
Wanjiku B, Yamamoto K, Klossek A, Schumacher F, Pischon H, Mundhenk L, Rancan F, Judd MM, Ahmed M, Zoschke C, Kleuser B, Rühl E, Schäfer-Korting M. Qualifying X-ray and Stimulated Raman Spectromicroscopy for Mapping Cutaneous Drug Penetration. Anal Chem 2019; 91:7208-7214. [PMID: 31090401 DOI: 10.1021/acs.analchem.9b00519] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Research on topical drug delivery relies on reconstructed human skin (RHS) in addition to ex vivo human and animal skin, each with specific physiological features. Here, we compared the penetration of dexamethasone from an ethanolic hydroxyethyl cellulose gel into ex vivo human skin, murine skin, and RHS. For comprehensive insights into skin morphology and penetration enhancing mechanisms, scanning transmission X-ray microscopy (STXM), liquid chromatography tandem-mass spectrometry (LC-MS/MS), and stimulated Raman spectromicroscopy (SRS) were combined. STXM offers high spatial resolution with label-free drug detection and is therefore sensitive to tissue damage. Despite differences in sample preparation and data analysis, the amounts of dexamethasone in RHS, detected and quantified by STXM and LC-MS/MS, were very similar and increased during the first 100 min of exposure. SRS revealed interactions between the gel and the stratum corneum or, more specifically, its protein and lipid structures. Similar to both types of ex vivo skin, higher protein-to-lipid ratios within the stratum corneum of RHS indicated reduced lipid amounts after 30 min of ethanol exposure. Extended ethanol exposure led to a continued reduction of lipids in the ex vivo matrixes, while protein integrity appeared to be compromised in RHS, which led to declining protein signals. In conclusion, LC-MS/MS proved the predictive capability of STXM for label-free drug detection. Combining STXM with SRS precisely dissected the penetration enhancing effects of ethanol. Further studies on topical drug delivery should consider the potential of these complementary techniques.
Collapse
Affiliation(s)
- Barbara Wanjiku
- Institute of Pharmacy (Pharmacology and Toxicology) , Freie Universität Berlin , Königin-Luise-Strasse 2 + 4 , 14195 Berlin , Germany
| | - Kenji Yamamoto
- Institute of Chemistry and Biochemistry (Physical Chemistry) , Freie Universität Berlin , Arnimallee 22 , 14195 Berlin , Germany
| | - André Klossek
- Institute of Chemistry and Biochemistry (Physical Chemistry) , Freie Universität Berlin , Arnimallee 22 , 14195 Berlin , Germany
| | - Fabian Schumacher
- Institute of Nutritional Science , University of Potsdam , Arthur-Scheunert-Allee 114-6 , 14558 Nuthetal , Germany.,Department of Molecular Biology , University of Duisburg-Essen , Hufelandstrasse 55 , 45147 Essen , Germany
| | - Hannah Pischon
- Institute of Veterinary Pathology , Freie Universität Berlin , Robert-von-Ostertag-Strasse 15 , 14163 Berlin , Germany
| | - Lars Mundhenk
- Institute of Veterinary Pathology , Freie Universität Berlin , Robert-von-Ostertag-Strasse 15 , 14163 Berlin , Germany
| | - Fiorenza Rancan
- Department of Dermatology and Allergy, Clinical Research Center for Hair and Skin Science , Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin , Charitéplatz 1 , 10117 Berlin , Germany
| | - Martyna M Judd
- Institute of Chemistry and Biochemistry (Physical Chemistry) , Freie Universität Berlin , Arnimallee 22 , 14195 Berlin , Germany
| | - Muniruddin Ahmed
- Institute of Pharmacy (Pharmacology and Toxicology) , Freie Universität Berlin , Königin-Luise-Strasse 2 + 4 , 14195 Berlin , Germany.,Department of Clinical Pharmacy and Pharmacology , University of Dhaka , Dhaka 1000 , Bangladesh
| | - Christian Zoschke
- Institute of Pharmacy (Pharmacology and Toxicology) , Freie Universität Berlin , Königin-Luise-Strasse 2 + 4 , 14195 Berlin , Germany
| | - Burkhard Kleuser
- Institute of Nutritional Science , University of Potsdam , Arthur-Scheunert-Allee 114-6 , 14558 Nuthetal , Germany
| | - Eckart Rühl
- Institute of Chemistry and Biochemistry (Physical Chemistry) , Freie Universität Berlin , Arnimallee 22 , 14195 Berlin , Germany
| | - Monika Schäfer-Korting
- Institute of Pharmacy (Pharmacology and Toxicology) , Freie Universität Berlin , Königin-Luise-Strasse 2 + 4 , 14195 Berlin , Germany
| |
Collapse
|
12
|
Yamamoto K, Klossek A, Fuchs K, Watts B, Raabe J, Flesch R, Rancan F, Pischon H, Radbruch M, Gruber AD, Mundhenk L, Vogt A, Blume-Peytavi U, Schrade P, Bachmann S, Gurny R, Rühl E. Soft X-ray microscopy for probing of topical tacrolimus delivery via micelles. Eur J Pharm Biopharm 2019; 139:68-75. [PMID: 30849430 DOI: 10.1016/j.ejpb.2019.03.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2018] [Revised: 01/04/2019] [Accepted: 03/04/2019] [Indexed: 12/27/2022]
Abstract
The penetration of topically applied tacrolimus formulated in micelles into murine skin is reported, measured by X-ray microscopy. Tacrolimus and micelles are probed for the first time by this high spatial resolution technique by element-selective excitation in the C 1s- and O 1s-regimes. This method allows selective detection of the distribution and penetration depth of drugs and carrier molecules into biologic tissues. It is observed that small, but distinct quantities of the drug and micelles, acting as a drug carrier, penetrate the stratum corneum. A comparison is made with the paraffin-based commercial tacrolimus ointment Protopic®, where local drug concentrations show to be low. A slight increase in local drug concentration in the stratum corneum is observed, if tacrolimus is formulated in micelles, as compared to Protopic®. This underscores the importance of the drug formulations for effective drug delivery. Time-resolved penetration shows presence of drug in the stratum corneum 100 min after formulation application, with penetration to deeper skin layers at 1000 min. High resolution micrographs give indications for a penetration pathway along the lipid membranes between corneocytes, but also suggest that the compound may penetrate corneocytes.
Collapse
Affiliation(s)
- K Yamamoto
- Physikalische Chemie, Freie Universität Berlin, Arnimallee 22, 14195 Berlin, Germany
| | - A Klossek
- Physikalische Chemie, Freie Universität Berlin, Arnimallee 22, 14195 Berlin, Germany
| | - K Fuchs
- Apidel SA, c/o The Business Harbour, 29 Quai du Mont Blanc, 1201 Geneva, Switzerland
| | - B Watts
- Swiss Light Source, Paul Scherrer Institut, Forschungsstraße 111, 5232 Villigen PSI, Switzerland
| | - J Raabe
- Swiss Light Source, Paul Scherrer Institut, Forschungsstraße 111, 5232 Villigen PSI, Switzerland
| | - R Flesch
- Physikalische Chemie, Freie Universität Berlin, Arnimallee 22, 14195 Berlin, Germany
| | - F Rancan
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany
| | - H Pischon
- Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag-Str. 15, 14163 Berlin, Germany
| | - M Radbruch
- Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag-Str. 15, 14163 Berlin, Germany
| | - A D Gruber
- Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag-Str. 15, 14163 Berlin, Germany
| | - L Mundhenk
- Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag-Str. 15, 14163 Berlin, Germany
| | - A Vogt
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany
| | - U Blume-Peytavi
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany
| | - P Schrade
- Abteilung für Elektronenmikroskopie at CVK, 13353 Berlin, Germany
| | - S Bachmann
- Abteilung für Elektronenmikroskopie at CVK, 13353 Berlin, Germany
| | - R Gurny
- Apidel SA, c/o The Business Harbour, 29 Quai du Mont Blanc, 1201 Geneva, Switzerland
| | - E Rühl
- Physikalische Chemie, Freie Universität Berlin, Arnimallee 22, 14195 Berlin, Germany
| |
Collapse
|
13
|
Graf C, Nordmeyer D, Sengstock C, Ahlberg S, Diendorf J, Raabe J, Epple M, Köller M, Lademann J, Vogt A, Rancan F, Rühl E. Shape-Dependent Dissolution and Cellular Uptake of Silver Nanoparticles. Langmuir 2018; 34:1506-1519. [PMID: 29272915 DOI: 10.1021/acs.langmuir.7b03126] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The cellular uptake and dissolution of trigonal silver nanoprisms (edge length 42 ± 15 nm, thickness 8 ± 1 nm) and mostly spherical silver nanoparticles (diameter 70 ± 25 nm) in human mesenchymal stem cells (hMSC's) and human keratinocytes (HaCaT cells) were investigated. Both particles are stabilized by polyvinylpyrrolidone (PVP), with the prisms additionally stabilized by citrate. The nanoprisms dissolved slightly in pure water but strongly in isotonic saline or at pH 4, corresponding to the lowest limit for the pH during cellular uptake. The tips of the prisms became rounded within minutes due to their high surface energy. Afterward, the dissolution process slowed down due to the presence of both PVP stabilizing Ag{100} sites and citrate blocking Ag{111} sites. On the contrary, nanospheres, solely stabilized by PVP, dissolved within 24 h. These results correlate with the finding that particles in both cell types have lost >90% of their volume within 24 h. hMSC's took up significantly more Ag from nanoprisms than from nanospheres, whereas HaCaT cells showed no preference for one particle shape. This can be rationalized by the large cellular interaction area of the plateletlike nanoprisms and the bending stiffness of the cell membranes. hMSC's have a highly flexible cell membrane, resulting in an increased uptake of plateletlike particles. HaCaT cells have a membrane with a 3 orders of magnitude higher Young's modulus than for hMSC. Hence, the energy gain due to the larger interaction area of the nanoprisms is compensated for by the higher energy needed for cell membrane deformation compared to that for spheres, leading to no shape preference.
Collapse
Affiliation(s)
- Christina Graf
- Physikalische und Theoretische Chemie, Institut für Chemie und Biochemie, Freie Universität Berlin , 14195 Berlin, Germany
| | - Daniel Nordmeyer
- Physikalische und Theoretische Chemie, Institut für Chemie und Biochemie, Freie Universität Berlin , 14195 Berlin, Germany
| | - Christina Sengstock
- Bergmannsheil University Hospital/Surgical Research, Ruhr-University Bochum , 44789 Bochum, Germany
| | - Sebastian Ahlberg
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin , 10117 Berlin, Germany
| | - Jörg Diendorf
- Inorganic Chemistry and Center for Nanointegration Duisburg-Essen (CeNIDE), University of Duisburg-Essen , 45117 Essen, Germany
| | - Jörg Raabe
- Swiss Light Source, Paul Scherrer Institut , 5232 Villigen, Switzerland
| | - Matthias Epple
- Inorganic Chemistry and Center for Nanointegration Duisburg-Essen (CeNIDE), University of Duisburg-Essen , 45117 Essen, Germany
| | - Manfred Köller
- Bergmannsheil University Hospital/Surgical Research, Ruhr-University Bochum , 44789 Bochum, Germany
| | - Jürgen Lademann
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin , 10117 Berlin, Germany
| | - Annika Vogt
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin , 10117 Berlin, Germany
| | - Fiorenza Rancan
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin , 10117 Berlin, Germany
| | - Eckart Rühl
- Physikalische und Theoretische Chemie, Institut für Chemie und Biochemie, Freie Universität Berlin , 14195 Berlin, Germany
| |
Collapse
|
14
|
Yamamoto K, Klossek A, Flesch R, Ohigashi T, Fleige E, Rancan F, Frombach J, Vogt A, Blume-Peytavi U, Schrade P, Bachmann S, Haag R, Hedtrich S, Schäfer-Korting M, Kosugi N, Rühl E. Core-multishell nanocarriers: Transport and release of dexamethasone probed by soft X-ray spectromicroscopy. J Control Release 2016; 242:64-70. [PMID: 27568290 DOI: 10.1016/j.jconrel.2016.08.028] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Revised: 08/16/2016] [Accepted: 08/23/2016] [Indexed: 11/26/2022]
Abstract
Label-free detection of core-multishell (CMS) nanocarriers and the anti-inflammatory drug dexamethasone is reported. Selective excitation by tunable soft X-rays in the O 1s-regime is used for probing either the CMS nanocarrier or the drug. Furthermore, the drug loading efficiency into CMS nanocarriers is determined by X-ray spectroscopy. The drug-loaded nanocarriers were topically applied to human skin explants providing insights into the penetration and drug release processes. It is shown that the core-multishell nanocarriers remain in the stratum corneum when applied for 100min to 1000min. Dexamethasone, if applied topically to human ex vivo skin explants using different formulations, shows a vehicle-dependent penetration behavior. Highest local drug concentrations are found in the stratum corneum as well as in the viable epidermis. If the drug is loaded to core-multishell nanocarriers, the concentration of the free drug is low in the stratum corneum and is enhanced in the viable epidermis as compared to other drug formulations. The present results provide insights into the penetration of drug nanocarriers as well as the mechanisms of controlled drug release from CMS nanocarriers in human skin. They are also compared to related work using dye-labeled nanocarriers and dyes that were used as model drugs.
Collapse
Affiliation(s)
- K Yamamoto
- Physikalische Chemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany
| | - A Klossek
- Physikalische Chemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany
| | - R Flesch
- Physikalische Chemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany
| | - T Ohigashi
- UVSOR Synchrotron Facility, Institute for Molecular Science, Okazaki 444-8585, Japan
| | - E Fleige
- Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany
| | - F Rancan
- Klinisches Forschungszentrum für Haut- und Haarforschung, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
| | - J Frombach
- Klinisches Forschungszentrum für Haut- und Haarforschung, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
| | - A Vogt
- Klinisches Forschungszentrum für Haut- und Haarforschung, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
| | - U Blume-Peytavi
- Klinisches Forschungszentrum für Haut- und Haarforschung, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
| | - P Schrade
- Abteilung für Elektronenmikroskopie at CVK, 13353 Berlin, Germany
| | - S Bachmann
- Abteilung für Elektronenmikroskopie at CVK, 13353 Berlin, Germany
| | - R Haag
- Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany
| | - S Hedtrich
- Institut für Pharmazie, Freie Universität Berlin, Königin-Luise-Str. 2-4, 14195 Berlin, Germany
| | - M Schäfer-Korting
- Institut für Pharmazie, Freie Universität Berlin, Königin-Luise-Str. 2-4, 14195 Berlin, Germany
| | - N Kosugi
- UVSOR Synchrotron Facility, Institute for Molecular Science, Okazaki 444-8585, Japan
| | - E Rühl
- Physikalische Chemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany.
| |
Collapse
|